Our Services
MARA Rating Products & Institutional Access
MARA provides standardized reimbursement risk assessments and structured access to calibrated payer-risk benchmarks.
All offerings are built on the same committee-based rating framework and 10-domain evaluation system.
Comparison Table
| Offering | Scope | Best For | Output Format |
| Single-Asset MARA Rating® | One drug–indication pair | Deal diligence, launch governance, pricing exposure review | Full structured report (PDF) + Internal Use License |
| Portfolio / TA Benchmarking | Multiple assets within a therapeutic area or portfolio | Comparative reimbursement risk analysis | Comparative benchmark report |
| MARA Analogue Intelligence | Cross-therapeutic analogue identification | Precedent discovery, risk stress-testing | Analogue mapping analysis |
| Market-Specific Extension | National reimbursement context | Country-level access stress testing | Structured market-specific report |
| Institutional Access | Multi-asset rating access | Enterprise governance & surveillance | Licensed database access |
Single-Asset MARA Rating®
The core committee-based reimbursement risk assessment.
Provides rating band, market access score, 10-domain evaluation, benchmarking, and surveillance status
Portfolio & Therapeutic Area Benchmarking
Side-by-side comparison of MARA Ratings across defined asset groups.
Designed to assess relative reimbursement exposure within a consistent framework.
MARA Analogue Intelligence
Identifies non-obvious cross-therapeutic comparators by mapping assets with similar MARA domain characteristics.
Reveals structural reimbursement precedents beyond traditional competitor sets.
Market-Specific Extensions
Applies the MARA framework to defined national HTA contexts while preserving scoring comparability.
Institutional Access & Research Agreements
Provides structured access to multiple MARA Ratings, surveillance updates, and licensed analytical outputs.
Available for pharmaceutical companies, investment institutions, government agencies, and academic bodies.
Disclaimer
The MARA Rating® is an independent opinion of a drug’s market access pharma risk profile and is provided for informational purposes only—not as investment, medical, legal or any other type of advice. All opinions, analyses, and recommendations are statements of opinion, not statements of fact, and are supplied “as-is” without warranty of any kind, express or implied, including accuracy, completeness, or fitness for any particular purpose. Users assume full responsibility for their decisions and any consequences thereof. MARA Rating Company expressly disclaims all liability for any outcomes arising from the use of, or actions taken based on, this report. Report may contain public sector information licensed under the Open Government Licence v3.0.© Crown copyright 2025 and others. All brand names are the property of their respective owners. For reimbursement & HTA professionals only – Not for patients, prescribers or the general public. Rights & Display. © MARA Rating Company AG. Viewing permitted. Reproduction, reprinting, redistribution, scraping, or public display of any MARA rating, badge, letter grade, chart, or the “Primary line” in marketing, IR, PR, sales, paid media, conference materials, or websites is prohibited without a valid MARA Display License. Non-licensees may link to this page/report but may not copy, repost, or restyle our content. Use must include the as-of date, our one-line explainer, and no edits to wording or artwork. No composite marks (do not combine the MARA badge with other logos/seals). No implication of MARA’s endorsement of efficacy, safety, price, or any transaction. “MARA”, “MARA Rating”, and the MARA badge are trademarks of MARA Rating Company AG. academic excerpt: up to 50 words of text (no badge/graphics) may be quoted with clear attribution and link. No commercial use. Misuse or corrections: contact sales@mararating.com.
Prices in CHF plus tax. Complimentary summaries are for informational purposes only. The MARA Rating® is an independent opinion of a drug’s market-access risk profile and is provided for informational purposes only—not as investment, medical, legal or any other type of advice. All opinions, analyses, and recommendations are statements of opinion, not statements of fact, and are supplied “as-is” without warranty of any kind, express or implied, including accuracy, completeness, or fitness for any particular purpose. Users assume full responsibility for their decisions and any consequences thereof. MARA expressly disclaims all liability for any outcomes arising from the use of, or actions taken based on, these reports.